Targeting bacteria to improve cancer therapy

Science

Volumn 330, Issue 6005, 2010, Pages 766-767

  Patel, Anand G ^a   Kaufmann, Scott H ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; DNA TOPOISOMERASE; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; ENZYME INHIBITOR; SN38 GLU; SN38-GLU;

BACTERIUM; CANCER; DRUG; ENZYME ACTIVITY; FUNCTIONAL MORPHOLOGY; INHIBITION; MICROBIAL ACTIVITY; TOXIC SUBSTANCE;

BREAST CANCER; CANCER CHEMOTHERAPY; COLORECTAL CARCINOMA; DNA DAMAGE; DRUG EFFICACY; DRUG SELECTIVITY; ESCHERICHIA COLI; HUMAN; INTESTINE FLORA; LUNG CANCER; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SHORT SURVEY; X RAY CRYSTALLOGRAPHY; ANIMAL; BACTERIUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MOUSE; NOTE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BACTERIA; CAMPTOTHECIN; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; ESCHERICHIA COLI; GLUCURONIDASE; INTESTINAL MUCOSA; MICE;

EID: 78149317234     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1198310     Document Type: Short Survey

References (9)

1. B. D. Wallace et al., Science 330, 831 (2010).
2. I. Husain, J. L. Mohler, H. F. Seigler, J. M. Besterman, Cancer Res. 54, 539 (1994).
3. Y. Pommier, Nat. Rev. Cancer 6, 789 (2006).
4. R. H. J. Mathijssen et al., Clin. Cancer Res. 7, 2182 (2001).
5. A. Sparreboom, W. C. Zamboni, in Cancer Chemotherapy & Biotherapy: Principles & Practice, B. A. Chabner, D. L. Longo, Eds. (Lippincott Williams & Wilkins, Philadelphia, 2005), pp. 371-413.
6. S. Nagar, R. L. Blanchard, Drug Metab. Rev. 38, 393 (2006).
7. K. Takasuna et al., Cancer Res. 56, 3752 (1996).
8. D. Flieger et al., Oncology 72, 10 (2007).
9. D. F. S. Kehrer et al., Clin. Cancer Res. 7, 1136 (2001).